Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 1
2019 1
2020 6
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Maurer MS, et al. Among authors: lousada i. Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4. Circ Heart Fail. 2019. PMID: 31480867 Free PMC article. Review.
The Impact of AL Amyloidosis: The Patient Experience.
Lousada I, Boedicker M. Lousada I, et al. Hematol Oncol Clin North Am. 2020 Dec;34(6):1193-1203. doi: 10.1016/j.hoc.2020.08.003. Epub 2020 Sep 30. Hematol Oncol Clin North Am. 2020. PMID: 33099433 Review.
Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
Mauermann ML, Clarke JO, Litchy WJ, Obici L, Lousada I, Gertz MA; Amyloidosis Forum Working Group Participants. Mauermann ML, et al. Among authors: lousada i. Adv Ther. 2023 Nov;40(11):4695-4710. doi: 10.1007/s12325-023-02637-4. Epub 2023 Sep 2. Adv Ther. 2023. PMID: 37658177 Free PMC article. Review.
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Cheng R, et al. Among authors: lousada i. Heart. 2024 Jan 24:heartjnl-2023-323502. doi: 10.1136/heartjnl-2023-323502. Online ahead of print. Heart. 2024. PMID: 38267197 Review.
Adverse Events of Physiotherapy Interventions in Parkinsonian Patients.
Caniça V, Bouça-Machado R, Rosa MM, Ferreira JJ; CNS Physiotherapy Study Group. Caniça V, et al. Mov Disord Clin Pract. 2022 May 25;9(6):744-750. doi: 10.1002/mdc3.13466. eCollection 2022 Aug. Mov Disord Clin Pract. 2022. PMID: 35937480 Free PMC article.
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.
Maurer MS, Dunnmon P, Fontana M, Quarta CC, Prasad K, Witteles RM, Rapezzi C, Signorovitch J, Lousada I, Merlini G. Maurer MS, et al. Among authors: lousada i. Circ Heart Fail. 2022 Jun;15(6):e009038. doi: 10.1161/CIRCHEARTFAILURE.121.009038. Epub 2022 Mar 25. Circ Heart Fail. 2022. PMID: 35331001 Free PMC article. Review.
19 results